SPARQL | HTML5 RDFa and Microdata document
  • http://rdf.wikipathways.org/Pathway/WP5426_r135049/Interaction/e2437
    • http://vocabularies.wikipathways.org/gpml#hasComment
      • http://rdf.wikipathways.org/Pathway/WP5426_r135049/Comment/ffd816565002dcf447eae3ed5f5cc2df
  • http://rdf.wikipathways.org/Pathway/WP5426_r135049/Comment/ffd816565002dcf447eae3ed5f5cc2df
    • http://www.w3.org/1999/02/22-rdf-syntax-ns#type
      • http://vocabularies.wikipathways.org/gpml#Comment
    • http://purl.org/dc/terms/isPartOf
      • http://rdf.wikipathways.org/Pathway/WP5426_r135049/Interaction/e2437
    • http://vocabularies.wikipathways.org/gpml#commentText
      • OCT4B-190 downregulated GSK-3β activity and HDAC6 expression simultaneously. Representative immunofluorescence images demonstrated the colocalization of OCT4B-190 (green), GSK-3 (blue) and HDAC6 (red) in primary neuronal cultures. This study for the first time revealed novel biological functions of OCT4B-190 in the experimental stroke, with implications for targeting GSK-3 and HDAC6 simultaneously as a possible neuroprotective strategy. NOTE:OCT4B is an alias for POU5F1.